SENSEONICS HOLDINGS INC (SENS) Stock News
NYSEARCA:SENS - American Stock Exchange - US81727U1051 - Common Stock
SENS Latest News and Analysis
Friday's session: top gainers and losers
These stocks are moving in today's session
These stocks are moving in today's session
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket
Thursday's after hours session: top gainers and losers
Thursday's after hours session: top gainers and losers
Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
Bargain Hunters Take Note: Insider Cluster-Buying At SENS
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
GERMANTOWN, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
$16 million upfront with the potential for an additional $16 million upon the exercise in full of warrants...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management...
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
SENS Stock Earnings: Senseonics Holdings Meets EPS, Misses Revenue for Q2 2024
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
Sidoti Events, LLC's Virtual June Small-Cap Conference
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
SENS Stock Earnings: Senseonics Holdings Meets EPS, Beats Revenue for Q1 2024
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
Eversense® CGM System Receives iCGM Designation by the US FDA
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
Senseonics stock slips after Q4 results (NYSE:SENS)
Senseonics Holdings (SENS) stock fell 9% despite a Q4 beat as analysts pointed to concerns over demand for its Eversense glucose monitoring device. Read more here.
Senseonics GAAP EPS of -$0.03 beats by $0.01, revenue of $8M beats by $0.38M (NYSE:SENS)
Senseonics beats expectations with Q4 earnings as GAAP EPS comes in at -$0.03, surpassing estimates by $0.01.
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Notable earnings after Thursday's close
Major earnings expected after the bell on Thursday include:Zscaler (ZS)Hewlett Packard Enterprise Company (HPE)Dell Technologies (DELL)Autodesk (ADSK)Veeva...
